Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified Sodium Hyaluronate–Recombinant Elastin Gel for Infraorbital Hollows
ChiCTR2600123040Phase 3Not yet recruiting
- Sponsor
- Hangzhou First People's Hospital
- Start
- Apr 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of modified sodium hyaluronate + recombinant elastin complex gel (2 arms), sponsored by Hangzhou First People's Hospital. Primary endpoint: Response rate for improvement of infraorbital hollows at 3 months after the last injection. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
modified sodium hyaluronate + recombinant elastin complex gel
Beyond the preview
Go deeper on ChiCTR2600123040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600123040.